The case for population-based screening for colorectal cancer

Nature Reviews Cancer

Volumn 2, Issue 1, 2002, Pages 65-70

  Schoen, Robert E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM ENEMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; ENDOSCOPY; EPIDEMIOLOGICAL DATA; HUMAN; OCCULT BLOOD; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SIGMOIDOSCOPY; WORLD HEALTH ORGANIZATION; ADENOMA; ADENOMATOUS POLYP; ADULT; AGED; CHEMISTRY; COLON POLYP; COLORECTAL TUMOR; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DISEASE COURSE; ECONOMICS; FECES; HEALTH CARE QUALITY; INTESTINE POLYP; MASS SCREENING; METHODOLOGY; MIDDLE AGED; ONCOGENE RAS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTION AND FORECASTING; RANDOMIZED CONTROLLED TRIAL; RISK; SENSITIVITY AND SPECIFICITY;

BARIUM DERIVATIVE; DIAGNOSTIC AGENT; TUMOR MARKER;

ADENOMA; ADENOMATOUS POLYPS; ADULT; AGED; BARIUM COMPOUNDS; COLONIC POLYPS; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; FECES; GENES, RAS; HUMANS; INTESTINAL POLYPS; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; PROGRAM EVALUATION; RANDOMIZED CONTROLLED TRIALS; RISK; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY; TUMOR MARKERS, BIOLOGICAL;

EID: 0036371375     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc705     Document Type: Review

References (54)

1. Greenlee, R. T., Murray, T., Bolden, S. & Wingo, P. A. Cancer statistics, 2000. CA Cancer J. Clin. 50, 7-33 (2000).
2. Ries, L. A. et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88, 2398-2424 (2000).
3. Kramer, B. S., Gohagan, J. K. & Prorok, P. C. (eds) Cancer Screening: Theory and Practice (Marcel Dekker, New York, 1999).
4. Bond, J. H. Polyp guideline: diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. The Practice Parameters Committee of the American College of Gastroenterology. Ann. Intern. Med. 119, 836-843 (1993); erratum 120, 347 (1994).
5. Terdiman, J. P., Conrad, P. G. & Sleisenger, M. H. Genetic testing in hereditary colorectal cancer: indications and procedures. Am. J. Gastroenterol. 94, 2344-2356 (1999).
6. Schoen, R. E., Weissfeld, J. L. & Kuller, L. H. Sigmoidoscopy use among primary care physicians. Prev. Med. 24, 249-254 (1995).
7. Kelly, R. B. & Shank, J. C. Adherence to screening flexible sigmoidoscopy in asymptomatic patients. Med. Care 30, 1029-1042 (1992).
8. Mandel, J. S., Church, T. R., Ederer, F. & Bond, J. H. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J. Natl Cancer Inst. 91, 434-437 (1999).
9. Hardcastle, J. D. et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348. 1472-1477 (1996).
10. Kronborg, O., Fenger, C., Olsen, J., Jorgensen, O. D. & Sondergaard, O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348, 1467-1471 (1996).
11. Lang, C. A. & Ransohoff, D. F. What can we conclude from the randomized controlled trials of fecal occult blood test screening? Eur. J. Gastroenterol. Hepatol. 10, 199-204 (1998).
12. Mandel, J. S. et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N. Engl. J. Med. 343, 1603-1607 (2000).
13. Lieberman, D. A. Cost-effectiveness model for colon cancer screening. Gastroenterology 109, 1781-1790 (1995).
14. Newcomb, P. A. et al. Screening sigmoidoscopy and colorectal cancer mortality. J. Natl Cancer Inst. 84, 1572-1575 (1992).
15. Selby, J. V., Friedman, G. D., Quesenberry, C. P. J. & Weiss, N. S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 326, 653-657 (1992).
16. Atkin, W. S., Cuzick, J., Northover, J. M. & Whynes, D. K. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 341, 736-740 (1993).
17. Atkin, W. S. et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 42, 560-565 (1998).
18. Cooper, G. S., Fortinsky, R. H., Hapke, R. & Landefeld, C. S. Factors associated with the use of flexible sigmoidoscopy as a screening test for the detection of colorectal carcinoma by primary care physicians. Cancer 82, 1476-1481 (1998).
19. Schoen, R. E., Weissfeld, J. L., Bowen, N. J., Switzer, G. & Baum, A. Patient satisfaction with screening flexible sigmoidoscopy. Arch. Intern. Med. 160, 1790-1796 (2000).
20. Schoenfeld, P. et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology 117, 312-318 (1999).
21. Podolsky, D. K. Going the distance - the case for true colorectal-cancer screening. N. Engl. J. Med. 343, 207-208 (2000).
22. Schoen, R. E. Interrupting the adenoma-carcinoma sequence: screening for adenomas and cancer, now and in the future. Semin. Gastrointest. Dis. 11, 219-228 (2000).
23. Lieberman, D. A., Weiss, D. G. & the Veterans Affairs Cooperative Study Group. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N. Engl. J. Med. 345, 555-560 (2001).
24. Schoen, R. E. et al. Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy? The Polyp Prevention Trial. Gastroenterology 115, 533-541 (1998).
25. Levin, T. R. et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. J. Am. Med. Assoc. 281, 1611-1617 (1999).
26. Rex, D. K., Johnson, D. A., Leberman, D. A., Burt, R. W. & Sonaenberg, A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am. J. Gastroenterol. 95, 868-877 (2000).
27. Winawer, S. J. et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 329, 1977-1981 (1993).
28. Citarda, F. et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 48, 812-815 (2001).
29. Thiis-Evensen, E. et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand. J. Gastroenterol. 34, 414-420 (1999).
30. Lieberman, D. A. et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N. Engl. J. Med. 343, 162-168 (2000).
31. Imperiale, T. F. et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N. Engl. J. Med. 343, 169-174 (2000).
32. Cooper, G. S., Yuan, Z., Landefeld, C. S., Johanson, J. F. & Rimm, A. A. A national population-based study of incidence of colorectal cancer and age. Implications for screening in older Americans. Cancer 75, 775-781 (1995).
33. Slattery, M. L. et al. A description of age, sex, and site distributions of colon carcinoma in three geographic areas. Cancer 78, 1666-1670 (1996).
34. Rex, D. K. et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112, 24-28 (1997).
35. Hixson, L. J., Fennerty, M. B., Sampliner, R. E. & Garewal, H. S. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest. Endosc. 37, 125-127 (1991).
36. Winawer, S. J. et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112, 594-642 (1997); errata 112, 1060 (1997) and 114, 625 (1998).
37. Cheong, Y., Farrow, R., Frank, C. S. & Stevenson, G. W. Utility of flexible sigmoidoscopy as an adjunct to double-contrast barium enema examination. Abdom. Imaging 23, 138-140 (1998).
38. Winawer, S. J. et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N. Engl. J. Med. 342, 1766-1772 (2000).
39. Fenlon, H. M. et al. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N. Engl. J. Med. 341, 1496-1503 (1999).
40. Rex, D. K. Vining, D. & Kopecky, K. K. An initial experience with screening for colon polyps using spiral CT with and without CT colography (virtual colonoscopy). Gastrointest. Endosc. 50, 309-313 (1999).
41. Hara, A. K. et al. Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity. Radiology 205, 59-65 (1997).
42. Dachman, A. H. et al. CT colonography with three-dimensional problem solving for detection of colonic polyps. Am. J. Roentgenol. 171, 989-995 (1998).
43. Sonnenberg, A., Delco, F. & Bauerfeind, P. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer? Am. J. Gastroenterol. 94, 2268-2274 (1999).
44. Sidransky, D. et al. Identification of RAS oncogene mutations in the stool of patients with curable colorectal tumors. Science 256, 102-105 (1992).
45. Minamoto, T. et al. Mutant KRAS in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesis. Cancer 75, 1520-1526 (1995).
46. Tobi, M., Luo, F. C. & Ronai, Z. Detection of KRAS mutation in colonic effluent samples from patients without evidence of colorectal carcinoma. J. Natl Cancer Inst. 86, 1007-1010 (1994).
47. Ahlquist, D. A. et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119, 1219-1227 (2000).
48. Ahlquist, D. A. Molecular stool screening for colorectal cancer. Using DNA markers may be beneficial, but large scale evaluation is needed. Br. Med. J. 321, 254-255 (2000).
49. Khandker, R. K. et al. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int. J. Technol. Assess. Health Care 16, 799-810 (2000).
50. Frazier, A. L., Colditz, G. A., Fuchs, C. S. & Kuntz, K. M. Cost-effectiveness of screening for colorectal cancer in the general population. J. Am. Med. Assoc. 284, 1954-1961 (2000).
51. Loeve, F. et al. Endoscopic colorectal cancer screening: a cost-saving analysis. J. Natl Cancer Inst. 92, 557-563 (2000).
52. Sonnenberg, A., Delco, F. & Bauerfeind, P. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer? Am. J. Gastroenterol 94, 2268-2274 (1999).
53. Schoen, R. E. Families at risk for colorectal cancer: risk assessment and genetic testing. J. Clin. Gastroenterol. 31, 114-120 (2000).
54. Fuchs, C. S. et al. A prospective study of family history and the risk of colorectal cancer. N. Engl. J. Med. 331, 1669-1674 (1994).